MEZZASOMA, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 295
EU - Europa 217
AS - Asia 165
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 679
Nazione #
US - Stati Uniti d'America 295
IT - Italia 102
IE - Irlanda 64
SG - Singapore 48
VN - Vietnam 37
HK - Hong Kong 34
CN - Cina 30
KR - Corea 11
FI - Finlandia 10
RO - Romania 7
UA - Ucraina 7
DE - Germania 6
RU - Federazione Russa 6
SE - Svezia 6
CZ - Repubblica Ceca 3
TR - Turchia 3
CH - Svizzera 2
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
DK - Danimarca 1
EU - Europa 1
NL - Olanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 679
Città #
Chandler 65
Dublin 64
Perugia 58
Singapore 40
Dong Ket 36
Hong Kong 34
Boardman 33
San Mateo 32
Santa Clara 18
Andover 11
Beijing 11
Rome 11
Seoul 11
Medford 10
Princeton 9
Lawrence 8
Wilmington 8
Bucharest 7
Helsinki 6
Redmond 6
Falls Church 5
Altamura 4
Munich 4
San Paolo di Civitate 4
Izmir 3
Los Angeles 3
Saint Petersburg 3
Ashburn 2
Campobasso 2
Collazzone 2
Dallas 2
Olomouc 2
Redwood City 2
Acireale 1
Ancona 1
Baku 1
Belgioioso 1
Brno 1
Copenhagen 1
Dearborn 1
Den Haag 1
Florence 1
Hays 1
Jinan 1
Lisbon 1
Norwalk 1
Piscataway 1
San Diego 1
Shanghai 1
Shijiazhuang 1
Todi 1
Vienna 1
Xingtai 1
Totale 536
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 109
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 84
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
Mutant NPM1 Maintains the Leukemic State through HOX Expression 66
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 59
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 57
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 57
Histone Deacetylase Inhibitors Induce Cell Growth Inhibition and Apoptosis in NPM1-Mutated AML Cells: A Possible Role for Epigenetic Therapies in AML Carrying NPM1 Gene Mutations 47
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 39
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 37
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 32
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 28
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations 22
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 19
Totale 727
Categoria #
all - tutte 3.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 2 1 1 5 18 0 0
2020/202186 0 1 0 1 14 3 0 19 10 2 0 36
2021/2022135 3 27 2 1 5 3 2 25 5 9 33 20
2022/2023198 9 32 1 13 19 18 3 8 78 7 8 2
2023/2024121 4 13 4 4 0 0 31 2 4 9 14 36
2024/2025119 17 21 25 13 31 12 0 0 0 0 0 0
Totale 727